Diabetic Kidney Disease Market
According to Intent Market Research, the Diabetic Kidney Disease Market is expected to grow from USD 9.5 Million in 2024-e at a CAGR of 10.7% to touch USD 19.4 Million by 2030. The Diabetic Kidney Disease Market is dominated by key players such as, Novo Nordisk, Merck & Co., AstraZeneca, Pfizer Inc., Boehringer Ingelheim, and Eli Lilly and Co.